Cure51

The company assembles data about long term survivors of cancer, thus hoping to crack the code on what keeps people alive.

Total raised

€15M

€15,000,000

Funding rounds

Investors

distinct backers

Active since

2024-03

latest 2024-03

Funding by year

EUR raised per year

High confidence

Raise-next likelihood32

base rate 44% for Seed

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2024-03-20	Seed	€15M	Hitachi Ventures,Life Extension Ventures,Olivier Pomel,Sofinnova Partners,Xavier Niel	View deal →

same sector or country